Navigation Links
Arcion Therapeutics to Present ARC-4558 Phase 2b Data for the Treatment of Pain Associated With Painful Diabetic Neuropathy at Upcoming Medical Meetings
Date:6/14/2011

BALTIMORE, June 14, 2011 /PRNewswire/ -- Arcion Therapeutics, a venture backed clinical stage biotechnology company developing topical therapies for chronic pain, today announced that data from the Phase 2b trial of ARC-4558 for the treatment of pain associated with painful diabetic neuropathy (PDN) will be the subject of two poster presentations at upcoming medical meetings.  The first poster will be presented at the American Diabetes Association's 71st Scientific Sessions, June 24-28, 2011, in San Diego, California.  The second poster will be presented at the Peripheral Nerve Society 2011 Biennial Meeting, June 25-29, 2011, in Potomac, Maryland.  ARC-4558 is a 0.1% gel formulation of clonidine hydrochloride for topical administration.  

Arcion previously announced positive top-line results from a Phase 2b double-blind, randomized, placebo-controlled clinical trial of ARC-4558 in adult patients with PDN. The U.S. Food and Drug Administration (FDA) granted Fast Track designation to ARC-4558 for the treatment of pain associated with PDN. The Company also held an End of Phase 2 meeting with the FDA and the ARC-4558 program is now poised to enter Phase 3 studies.

Abstract Information

Topical Clonidine for Treatment of Painful Diabetic Neuropathy: a Randomized Double Blind Phase IIb Clinical Trial
Meeting: American Diabetes Association's 71st Scientific Sessions
Presenter: James N. Campbell, M.D. and William Schmidt, Ph.D.
Session Day / Time: Saturday, June 25, 2011, 10:00 a.m. to 7:30 p.m.
Additional showing: The poster will also be part of the "Pharmacologic Treatment of Diabetes-Diabetes Complications" tour session on June 27, 2011, 12:00 p.m. to 1:00 p.m.

Response to Topical Capsaicin Correlates with the Efficacy of Topical Clonidine as a Trea
'/>"/>

SOURCE Arcion Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Cell Therapeutics on Preliminary List of Additions to Russell 3000® Index and Russell Global Index
2. Northwest Biotherapeutics Announces Change and Expansion of Management Team
3. Northwest Biotherapeutics Announces Series of Financing Arrangements
4. Healthpoint Biotherapeutics Acquires Regranex® Gel
5. Halozyme Therapeutics to Present at the Jefferies 2011 Global Healthcare Conference on June 9
6. Reportlinker Adds Osteosarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2017
7. Juventas Therapeutics Demonstrates JVS-100 Delivery to Patients with Heart Failure is Safe and Provides Clinical Benefit
8. Northwest Biotherapeutics to Present at American Society of Cell and Gene Therapy
9. Northwest Biotherapeutics and the Fraunhofer Institute for Cell Therapy and Immunology are Partnering for Clinical Trials and Compassionate Use Cases in Europe
10. Nile Therapeutics to Transition to OTCQB Marketplace
11. Halozyme Therapeutics Reports First Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Oven Industries announces the new 5R1-1400 ... or via a PC through the TTL level UART ... half inches square can deliver up to 15 AMPS ... noise solid state relay. Operator safety is achieved with ... port and sensor input. Specifications: Input Voltage 85 ...
(Date:5/22/2013)... iLuv Creative Technology, the premier provider ... mobile lifestyle, announces they are now shipping MultiCharger-X, an ... iPad devices efficiently. Winner of the 2013 internationally recognized ... award, MultiCharger-X is revolutionizing the way businesses, schools, and ... , MultiCharger-X (iAD910) combines the best ...
(Date:5/22/2013)... May 22, 2013 The Conference ... Disruptive Innovations to Advance Clinical Trials conference taking place ... in Boston, MA. , Disruptive thinkers from Novartis, ... more share bold approaches to reduce expensive infrastructure, engage ... innovation needs to be big, or novel, or it ...
(Date:5/22/2013)... , May 22, 2013  Empire Genomics ... for a patent pending novel genomic biomarker from ... diagnostic test that could help in diagnosing and ... cancer.  Neuroendocrine prostate cancer (NEPC) ... that can arise de novo, but more commonly ...
Breaking Biology Technology:New AC Temperature Controller Announced by Oven Industries 2iLuv Now Shipping the All New MultiCharger-X 2iLuv Now Shipping the All New MultiCharger-X 3Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches 2Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer 2
... Madison, Wis. John Hawks has a cardinal rule ... write it down." , ,The University of Wisconsin-Madison anthropologist practices ... it down, but share it with the world via academic ... that solved Hawks' practical academic needs and also happened to ...
... ago, we talked about Venture Capital investments during 2005 in ... compared against the general VC landscape. I also promised to ... region and stage of development for 2005. , ,The information ... by PriceWaterhouse Cooper's MoneyTree Survey . It is also ...
... making navigation and medical devices will receive funding ... of Commerce Technology Venture Fund program. ... to develop a navigational tool for firefighters. It ... services necessary to complete preliminary prototype development services. ...
Cached Biology Technology:Anthropology professor's blog raises public interest 2Anthropology professor's blog raises public interest 3Midwest plays small role in VC investment, angel groups to the rescue 2Midwest plays small role in VC investment, angel groups to the rescue 3Midwest plays small role in VC investment, angel groups to the rescue 4Midwest plays small role in VC investment, angel groups to the rescue 5
(Date:5/21/2013)... at USC have found that a class of pharmaceuticals ... , The drugs, known as "TSPO ligands," are ... looked at the effects of TSPO ligand in young ... and in aged mice when pathology was quite severe," ... School of Gerontology. "TSPO ligand reduced measures of pathology ...
(Date:5/21/2013)... University of Michigan Water Center today awarded 12 ... Lakes restoration and protection efforts. , The two-year ... projects, including efforts to track the remediation of ... to control non-native weedy plant invasions; study chromosomal ... responses to restoration activities. , The grants were ...
(Date:5/21/2013)... Think keeping in shape is an uphill battle? Try ... and prolonged weightlessness withers muscle and bone. , That,s ... will address with a new three-year, $1.2 million grant ... to exercise during multiyear exploratory missions. , "You could ... if you can,t get them to stick to it, ...
Breaking Biology News(10 mins):Drugs found to both prevent and treat Alzheimer's disease in mice 2U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4Fueling fitness on the final frontier 2
... As part of its 50th anniversary events, the University ... celebrating 21 years of continuous support for research in ... conference. Citizen Science Past, Present & Future, ... of Lifelong Learning, will showcase longstanding research from the ...
... throughout the world stand to benefit from a new ... Australia that aims to develop more advanced fertilizers ... Technology Research Centre, to be based at the University ... facilities. The new centre has been established by ...
... ANN ARBOR, Mich.---Did modern birds originate around the time ... far longer" The question is at the ... between paleontologists, whose estimates are based on the fossil ... study evolutionary history. A new analysis by researchers ...
Cached Biology News:Citizen Science -- a celebration of partnership between academia and local people 2Fertilizer research center an Australian first 2Avian origins: new analysis confirms ancient beginnings 2
BD Falcon Center-well 60 mm In Vitro Fertilization (IVF) Dish, nonembryotoxic, noncytotoxic, tissue-culture treated polystyrene. (20/sp, 500/ca) Packaging: 20 / sleeve, 500 / case ...
Gelatin 100 mm Culture Dishes...
BD BioCoat BD MatrigelTM Matrix 100 mm Culture Dishes for hepatocytes, tissue-culture treated polystyrene with a uniform application of MATRIGEL Matrix....
... an internal standard for the quantification of ... 5-OxoETE is a polyunsaturated keto acid formed ... neutrophils. It stimulates cytosolic calcium levels in ... 5-OxoETE selectively stimulates the migration and degranulation ...
Biology Products: